(Q44708516)

5 December 2017

title

Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma (English)

1 reference

5 December 2017

4

1 reference

5 December 2017

Rob J van Klaveren

1

1 reference

5 December 2017

Joachim G J V Aerts

2

1 reference

5 December 2017

Hein de Bruin

3

1 reference

5 December 2017

Christian Manegold

5

1 reference

5 December 2017

Jan P van Meerbeeck

6

1 reference

5 December 2017

publication date

1 January 2004

1 reference

5 December 2017

1 reference

5 December 2017

volume

43

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

63-69

1 reference

Reporting results of cancer treatment

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900292-7

7 January 2021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900292-7

7 January 2021

Will there be resistance to the RECIST (Response Evaluation Criteria in Solid Tumors)?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900292-7

7 January 2021

Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900292-7

7 January 2021

Re: Measure once or twice--does it really matter?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900292-7

7 January 2021

Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900292-7

7 January 2021

Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900292-7

7 January 2021

Outstanding problems with response evaluation criteria in solid tumors (RECIST) in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900292-7

7 January 2021

Significance of and problems in adopting response evaluation criteria in solid tumor RECIST for assessing anticancer effects of advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900292-7

7 January 2021

10.1016/S0169-5002(03)00292-7

Identifiers

DOI

1 reference

5 December 2017

1 reference